<- Go Home

YD Bio Limited

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Market Cap

$861.4M

Volume

5.8K

Cash and Equivalents

$3.1M

EBITDA

-$1.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$155.4K

Profit Margin

30.44%

52 Week High

$31.00

52 Week Low

$5.30

Dividend

N/A

Price / Book Value

2.68

Price / Earnings

-9.50

Price / Tangible Book Value

4.52

Enterprise Value

$858.3M

Enterprise Value / EBITDA

-640.48

Operating Income

-$1.5M

Return on Equity

42.69%

Return on Assets

-25.43

Cash and Short Term Investments

$3.1M

Debt

$22.3K

Equity

$6.6M

Revenue

$510.4K

Unlevered FCF

-$3.9M

Sector

Biotechnology

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches